These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27981420)

  • 21. Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view.
    Schneider M; Retz W; Coogan A; Thome J; Rösler M
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256 Suppl 1():i32-41. PubMed ID: 16977550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Value and Limitations of MRI Neuroimaging in Psychiatry.
    Kalin NH
    Am J Psychiatry; 2021 Aug; 178(8):673-676. PubMed ID: 34383565
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurobiology of attention deficit/hyperactivity disorder.
    Purper-Ouakil D; Ramoz N; Lepagnol-Bestel AM; Gorwood P; Simonneau M
    Pediatr Res; 2011 May; 69(5 Pt 2):69R-76R. PubMed ID: 21289544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting clinical symptoms of attention deficit hyperactivity disorder based on temporal patterns between and within intrinsic connectivity networks.
    Wang XH; Jiao Y; Li L
    Neuroscience; 2017 Oct; 362():60-69. PubMed ID: 28843999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder.
    Shim SH; Yoon HJ; Bak J; Hahn SW; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():237-44. PubMed ID: 27103462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Skeptical review of the state of neuroimaging in attention deficit hyperactivity disorder].
    Castellanos FX
    Medicina (B Aires); 2022 Feb; 82 Suppl 1():28-32. PubMed ID: 35171804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging genetics in ADHD: a focus on cognitive control.
    Durston S; de Zeeuw P; Staal WG
    Neurosci Biobehav Rev; 2009 May; 33(5):674-89. PubMed ID: 18789356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Brain Abnormalities of Attention-Deficit/Hyperactivity Disorder With Oppositional Defiant Disorder.
    Noordermeer SDS; Luman M; Greven CU; Veroude K; Faraone SV; Hartman CA; Hoekstra PJ; Franke B; Buitelaar JK; Heslenfeld DJ; Oosterlaan J
    Biol Psychiatry; 2017 Nov; 82(9):642-650. PubMed ID: 28911901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry.
    Cherkasova MV; Hechtman L
    Can J Psychiatry; 2009 Oct; 54(10):651-64. PubMed ID: 19835672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of ADHD associated genes in neurodevelopment.
    Dark C; Homman-Ludiye J; Bryson-Richardson RJ
    Dev Biol; 2018 Jun; 438(2):69-83. PubMed ID: 29608877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary factors in attention deficit hyperactivity disorder].
    Fliers EA; Franke B; Buitelaar JK
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1726-9. PubMed ID: 16114287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of Clinical Neuroimaging to the Understanding of the Pharmacology of Methylphenidate.
    Zimmer L
    Trends Pharmacol Sci; 2017 Jul; 38(7):608-620. PubMed ID: 28450072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic advances in attention deficit hyperactivity disorder].
    Ramos-Quiroga JA; Ribasés-Haro M; Bosch-Munsó R; Cormand-Rifà B; Casas M
    Rev Neurol; 2007 May; 44 Suppl 3():S51-2. PubMed ID: 17523112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention-deficit/hyperactivity disorder: perspectives from neuroimaging.
    Hale TS; Hariri AR; McCracken JT
    Ment Retard Dev Disabil Res Rev; 2000; 6(3):214-9. PubMed ID: 10982499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying imaging genetics to ADHD: the promises and the challenges.
    Wu Z; Yang L; Wang Y
    Mol Neurobiol; 2014 Oct; 50(2):449-62. PubMed ID: 24687870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroimaging in attention deficit hyperactivity disorder].
    Martín Fernández-Mayoralas D; Fernández-Jaén A; García-Segura JM; Quiñones-Tapia D
    Rev Neurol; 2010 Mar; 50 Suppl 3():S125-33. PubMed ID: 20200840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrete Global but No Focal Gray Matter Volume Reductions in Unmedicated Adult Patients With Attention-Deficit/Hyperactivity Disorder.
    Maier S; Perlov E; Graf E; Dieter E; Sobanski E; Rump M; Warnke A; Ebert D; Berger M; Matthies S; Philipsen A; Tebartz van Elst L
    Biol Psychiatry; 2016 Dec; 80(12):905-915. PubMed ID: 26115789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.